Inflammation and sarcopenia: A systematic review and meta-analysis

Chung, 2009, Molecular inflammation: underpinnings of aging and age-related diseases, Ageing Res. Rev., 8, 18, 10.1016/j.arr.2008.07.002

Cruz-Jentoft, 2010, Sarcopenia: european consensus on definition and diagnosis: report of the european working group on sarcopenia in older people, Age Ageing, 39, 412, 10.1093/ageing/afq034

Morley, 2011, Sarcopenia with limited mobility: an international consensus, J. Am. Med. Dir. Assoc., 12, 403, 10.1016/j.jamda.2011.04.014

Lang, 2010, Sarcopenia: etiology, clinical consequences, intervention, and assessment, Osteoporos. Int., 21, 543, 10.1007/s00198-009-1059-y

Landi, 2012, Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study, Clin. Nutr., 31, 652, 10.1016/j.clnu.2012.02.007

Landi, 2013, Sarcopenia and mortality risk in frail olderpersons aged 80 years and older: results from iLSIRENTE study, Age Ageing, 42, 203, 10.1093/ageing/afs194

Bianchi, 2015, The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study, J. Gerontol. Ser. A Biol. Sci. Med. Sci.

Jo, 2012, Potential mechanisms underlying the role of chronic inflammation in age-related muscle wasting, Aging Clin. Exp. Res., 24, 412, 10.1007/BF03654825

Budui, 2015, The pathogenetic bases of sarcopenia, Clin. Cases Miner. Bone Metab., 12, 22

Visser, 2002, Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study, J. Gerontol. Med. Sci., 57A, M326, 10.1093/gerona/57.5.M326

Schaap, 2006, Inflammatory markers and loss of muscle mass (Sarcopenia) and strength, Am. J. Med., 119, 526, 10.1016/j.amjmed.2005.10.049

Thomas, 2007, Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia, Clin. Nutr., 26, 389, 10.1016/j.clnu.2007.03.008

von Elm, 2008, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guildelines for reporting observational studies, J. Clin. Epidemiol., 61, 344, 10.1016/j.jclinepi.2007.11.008

Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration, PLoS Med., 6, e1000100, 10.1371/journal.pmed.1000100

Solmi, 2015, Inflammatory cytokines and anorexia nervosa: a meta-analysis of cross-sectional and longitudinal studies, Psychoneuroendocrinology, 51, 237, 10.1016/j.psyneuen.2014.09.031

Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186

Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446

Duval, 2000, Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis, Biometrics, 56, 455, 10.1111/j.0006-341X.2000.00455.x

Lim, 2015, Monocyte chemoattractant protein-1: A proinflammatory cytokine elevated in sarcopenic obesity, Clin. Interv. Aging, 10, 605

Atkins, 2014, Low muscle mass in older men: the role of lifestyle, diet and cardiovascular risk factors, J. Nutr. Heal. Aging, 18, 26, 10.1007/s12603-013-0336-9

Can, 2016, Serum markers of inflammation and oxidative stress in sarcopenia, Aging Clin. Exp. Res., 10.1007/s40520-016-0626-2

M. T. Dutra, B. Pereira Avelar, V. C. Souza, M. Bottaro, R. Jac O Oliveira, O. Avio, T. N. Obrega, R. Moreno Lima, R. M. Lima, Relationship between sarcopenic obesity-related phenotypes and inflammatory markers in postmenopausal women Summary Correspondence.

El Maghraoui, 2016, Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?, BMC Musculoskelet. Disord., 10.1186/s12891-016-1155-z

H. Fujikawa T. Araki Y. Okita S. Kondo M. Kawamura J. Hiro Y. Toiyama M. Kobayashi K. Tanaka Y. Inoue Y. Mohri K. Uchida M. Kusunoki, Impact of sarcopenia on surgical site infection after restorative proctocolectomy for ulcerative colitis Surg. Today.

H. Ishihara, T. Kondo, K. Omae, T. Takagi, J. Iizuka, H. Kobayashi, and K. Tanabe, Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment.

P. Joppa R. Tkacova F.M. Franssen C. Hanson S.I. Rennard E.K. Silverman M.-L.N. McDonald P.M. Calverley R. Tal-Singer M.A. Spruit K. Kenn E.F. Wouters, E.P. Rutten Sarcopenic Obesity, Functional Outcomes and Systemic Inflammation in Patients With Chronic Obstructive Pulmonary Disease.

E. Y. Kim, Y. S. Kim, J.-Y. Seo, I. Park, H. K. Ahn, Y. M. Jeong, J. H. Kim, and N. Kim, The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer.

Kim, 2013, Serum adipocyte fatty acid-binding protein levels are independently associated with sarcopenic obesity, Diabetes Res. Clin. Pract., 101, 210, 10.1016/j.diabres.2013.05.014

Kim, 2013, Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study, Clin. Endocrinol. (Oxf)., 78, 525, 10.1111/j.1365-2265.2012.04433.x

Kim, 2014, Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease, Clin. Nutr., 33, 64, 10.1016/j.clnu.2013.04.002

Levine, 2012, The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning, Obesity, 20, 2101, 10.1038/oby.2012.20

K. E. Rollins, N. Tewari, A. Ackner, A. Awwad, S. Madhusudan, I. A. Macdonald, K. C. H. Fearon, D. N. Lobo, The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma, (2016).

Sergi, 2011, Changes in healthy elderly women’s physical performance: a 3-year follow-up, Exp. Gerontol., 46, 929, 10.1016/j.exger.2011.08.008

Tay, 2015, Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults, Age (Omaha), 10.1007/s11357-015-9860-3

Yang, 2015, Association of sarcopenic obesity with higher serum high-sensitivity c-reactive protein levels in Chinese older males—a community-based study (Taichung Community Health Study-Elderly, TCHS-E), PLoS One

Van De Bool, 2015, Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD, Eur. Respir. J., 10.1183/09031936.00197314

Soysal, 2016, Inflammation and frailty In the elderly: a systematic review and meta-analysis, Ageing Res. Rev., 10.1016/j.arr.2016.08.006

Fearon, 2011, Definition and classification of cancer cachexia: an international consensus, Lancet Oncol., 10.1016/S1470-2045(10)70218-7

Argilés, 2015, Cachexia and sarcopenia: mechanisms and potential targets for intervention, Curr. Opin. Pharmacol., 22, 100, 10.1016/j.coph.2015.04.003

Zembroń-Łacny, 2014, Sarcopenia: monitoring, molecular mechanisms, and physical intervention, Physiol. Res., 63, 683, 10.33549/physiolres.932692

Calvani, 2015, Biomarkers for physical frailty and sarcopenia: state of the science and future developments, J. Cachexia Sarcopenia Muscle, 10.1002/jcsm.12051

Berkley, 2006, Sex and gender differences in pain and inflammation: a rapidly maturing field, Am. J. Physiol. Regul. Integr. Comp. Physiol., 291, R241, 10.1152/ajpregu.00287.2006

Rieu, 2009, Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats, J. Physiol., 587, 5483, 10.1113/jphysiol.2009.178319

Landi, 2013, Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: results from the ilSIRENTE study, J. Am. Med. Dir. Assoc., 14, 626, 10.1016/j.jamda.2013.04.012